Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-27T04:25:32.091Z Has data issue: false hasContentIssue false
  • English
  • Français

Epley's manoeuvre versus Epley's manoeuvre plus labyrinthine sedative as management of benign paroxysmal positional vertigo: prospective, randomised study

Published online by Cambridge University Press:  27 January 2011

I Sundararajan ,
V Rangachari ,
V Sumathi  and
K Kumar
I Sundararajan
Affiliation:
Department of Otolaryngology, Sundaram Medical Foundation, Chennai, India
V Rangachari*
Affiliation:
Department of Otolaryngology, Sundaram Medical Foundation, Chennai, India
V Sumathi
Affiliation:
Department of Otolaryngology, Sundaram Medical Foundation, Chennai, India
K Kumar
Affiliation:
Department of Otolaryngology, Sundaram Medical Foundation, Chennai, India
*
Address for correspondence: Dr Vijay Rangachari, 5/114, Ground Floor, Vaishali, Ghaziabad, Uttar Pradesh, India Fax: +91 120 4173010 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

We report a prospective, randomised study of 51 patients with benign paroxysmal positional vertigo treated with Epley's manoeuvre alone or Epley's manoeuvre plus labyrinthine sedative, at Sundaram Medical Foundation, Chennai, India.

Aim:

To compare the efficacy of Epley's manoeuvre versus Epley's manoeuvre plus labyrinthine sedative in the treatment of benign paroxysmal positional vertigo.

Materials and methods:

Consecutive patients were selected based on history and positive Dix–Hallpike test. Patients were randomised to receive either Epley's manoeuvre alone or Epley's manoeuvre plus labyrinthine sedative for one week. Both groups were followed up for four weeks.

Results:

Univariate analysis showed that one- and four-week outcomes were influenced by the number of episodes, symptom duration and treatment type. Multivariate logistic regression analysis showed that the one-week outcome was significantly influenced by symptom duration and treatment type, while the four-week outcome was significantly influenced by symptom duration alone. Patients receiving Epley's manoeuvre alone showed better recovery than those receiving both Epley's manoeuvre and labyrinthine sedative.

Conclusion:

Labyrinthine sedatives do not aid recovery from benign paroxysmal positional vertigo when used in addition to Epley's manoeuvre.

Keywords

Vertigo, ParoxysmalTherapeutics
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 125 , Issue 6 , June 2011 , pp. 572 - 575
Copyright
Copyright © JLO (1984) Limited 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Philip, R, Prepageran, N. Dizziness, a review of walk-in patients at a specialized neurotology clinic. Med J Malaysia 2009;64:56–8Google Scholar
2Pearce, JM. Benign positional vertigo and barany's caloric reactions. Eur Neurol 2007;57:246–8CrossRefGoogle ScholarPubMed
3Dix, MR, Hallpike, CS. The pathology, symptomatology and diagnosis of certain common disorders of the vestibular system. Proc R Soc Med 1952;45:341–54Google ScholarPubMed
4Epley, JM. New dimensions of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1980;88:599–605CrossRefGoogle ScholarPubMed
5Epley, JM. The canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992;107:399–404CrossRefGoogle ScholarPubMed
6Simhardi, S, Panda, N, Raghunathan, M. Efficacy of particle repositioning maneuver in BPPV: a prospective study. Am J Otolaryngol 2003;24:355–60Google Scholar
7Froehling, DA, Bowen, JM, Mohr, DN, Brey, RH, Beatty, CW, Wollan, PC et al. The canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo: a randomized controlled trial. Mayo Clin Proc 2000;75:695–700CrossRefGoogle ScholarPubMed
8Hilton, M, Pinder, D. The Epley (canalith repositioning) manoeuver for benign paroxysmal positional vertigo – a systematic review. Cochrane Database Syst Rev 2004;(2):CD003162Google Scholar
9Hain, TC, Uddin, M. Pharmacological treatment of vertigo. CNS Drugs 2003;17:85–100CrossRefGoogle ScholarPubMed
10Neuhauser, HK. Epidemiology of vertigo. Curr Opin Neurol 2007;20:40–6CrossRefGoogle ScholarPubMed
11Bhattacharyya, N, Baugh, RF, Orvidas, L, Barrs, D, Bronston, LJ, Cass, S et al. Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2008;139:49–81CrossRefGoogle ScholarPubMed
12Neuhauser, HK, von Brevern, M, Radtke, A, Lezius, F, Feldmann, M, Ziese, T et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005;65:898–904CrossRefGoogle ScholarPubMed
13Nunez, RA, Cass, SP, Furman, JM. Short- and long-term outcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2000;122:647–52CrossRefGoogle Scholar
14Korres, S, Balatsouras, DG, Ferekidis, E. Prognosis of patients with benign paroxysmal positional vertigo treated with repositioning manoeuvres. J Laryngol Otol 2006;120:528–33CrossRefGoogle ScholarPubMed